5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The France Veterinary Healthcare Market is segmented By Product (By Therapeutics, and By Diagnostics), and By Animal Type
Increasing demand to curb chronic and zoonotic diseases in livestock and pet animals is the key driver to this market. The global livestock population has been experiencing rapid growth over the past few decades. In developing countries of France, the demand for livestock products is increasing. Moreover,rising concerns about food security and animal husbandries are anticipated to boost demand for veterinary pharmaceuticals and vaccines for livestock population in the near future.
The regional market is driven by technological advancements in veterinary health care, and this is anticipated to offer future growth opportunities. These advancements include advent of efficient information management systems, animal owner mobile technology, and vaccine banks. High focus on innovation in animal health has given rise to certain measures that are strengthening market growth prospects. For instance, the Innovative Medicines Initiative (IMI) is a public-private partnership to support collaborative research in order to boost innovation in veterinary pharmaceuticals in France.
Industry players are trying to develop innovative products such as mAbs and carrier drugs for better treatment outcome. For instance, in 2017, Zoetis launched Cytopoint, a monoclonal antibody indicated for canine atopic dermatitis, which became a blockbuster drug in 2018, which is expected to propel the market in the near future.
As per the scope of the report, Veterinary medicines are associated with treatment, diagnosis, and prevention of diseases among animals. It covers a variety of animal species, both, in domestic and wild.
Report scope can be customized per your requirements. Click here.
The Vaccines segment in France veterinary healthcare market is expected to register healthy growth during the forecast period due to the presence of good healthcare infrastructure in France and it is also experiencing positive trends in the R&D developments. Inter-Governmental Organizations are making reforms to ensure health through the process of surveillance and vaccination. Also, awareness about pet health care and diagnostic techniques in the veterinary health care market will drive the market.
To understand key trends, Download Sample Report
The major players in the France Veterinary Healthcare Market include - Bayer Healthcare, Boehringer Ingelheim International GmbH, Ceva Animal Health, Inc., Elanco, IDEXX Laboratories, Merck & Co. Inc., Vetoquinol, and Zoetis Inc.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare
4.2.2 Risk of Emerging Zoonosis
4.3 Market Restraints
4.3.1 Lack of Infrastructure and Funding
4.3.2 Use of Counterfeit Medicines
4.3.3 Increasing Costs of Animal Testing and Veterinary Services
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 By Therapeutics
126.96.36.199 Medical Feed Additives
188.8.131.52 Other Therapeutics
5.1.2 By Diagnostics
184.108.40.206 Immunodiagnostic Tests
220.127.116.11 Molecular diagnostics
18.104.22.168 Diagnostic Imaging
22.214.171.124 Clinical Chemistry
126.96.36.199 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.6 Other Animals
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer Healthcare
6.1.2 Boehringer Ingelheim International GmbH
6.1.3 Ceva Animal Health, Inc.
6.1.5 IDEXX Laboratories
6.1.6 Merck & Co. Inc.
6.1.8 Zoetis Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments